Abstract PS5-26: Pd-l1 mRNA expression in plasma-derived exosomes predicts prognosis and response to anti-pd-l1 antibodies in unresectable locally advanced triple negative breast cancer (TNBC) treated with atezolizumab-paclitaxel

Authors: Lucrezia Raimondi, Laura Di Benedetto, Victoria Bitca, Gian Paolo Spinelli

Published: 2021-02-15

DOI: 10.1158/1538-7445.sabcs20-ps5-26

Source: Full article